Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 5.83B | 5.63B | 5.86B | 5.74B | 4.54B |
Gross Profit | 5.00B | 4.83B | 5.02B | 4.87B | 3.82B |
EBITDA | 1.75B | 1.94B | 2.19B | 2.34B | 1.62B |
Net Income | 367.09M | 628.71M | 924.47M | 1.12B | 610.86M |
Balance Sheet | |||||
Total Assets | 20.48B | 19.06B | 18.12B | 17.30B | 14.65B |
Cash, Cash Equivalents and Short-Term Investments | 3.47B | 1.54B | 2.06B | 2.70B | 1.19B |
Total Debt | 0.00 | 6.33B | 6.75B | 6.10B | 4.76B |
Total Liabilities | 12.98B | 11.89B | 11.60B | 11.41B | 9.80B |
Stockholders Equity | 7.50B | 7.17B | 6.53B | 5.89B | 4.85B |
Cash Flow | |||||
Free Cash Flow | 1.45B | -1.54B | -994.29M | -190.30M | 93.92M |
Operating Cash Flow | 1.45B | 1.45B | 1.73B | 1.95B | 1.54B |
Investing Cash Flow | -2.89B | -2.05B | -2.42B | -1.87B | -1.13B |
Financing Cash Flow | 895.11M | 66.53M | 59.80M | 1.43B | 287.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $2.93B | 12.33 | 22.80% | 1.61% | 7.31% | 91.99% | |
76 Outperform | $2.93B | 12.33 | 22.80% | 1.61% | 7.31% | 91.99% | |
70 Outperform | $50.96B | 20.30 | 30.17% | 0.90% | 7.20% | 4.56% | |
70 Outperform | $50.96B | 20.30 | 30.17% | 0.90% | 7.20% | 4.56% | |
67 Neutral | £2.80B | 13.41 | 4.69% | 3.43% | 2.35% | -24.51% | |
62 Neutral | $7.00B | 14.81 | 16.41% | 1.89% | 6.21% | 47.05% | |
62 Neutral | $7.00B | 14.81 | 16.41% | 1.89% | 6.21% | 47.05% | |
61 Neutral | $10.89B | 35.79 | 4.52% | ― | 0.98% | -35.16% | |
56 Neutral | $3.47B | 38.00 | 15.74% | 1.16% | -3.52% | -46.60% | |
51 Neutral | $4.56B | 30.61 | 9.60% | 1.94% | 8.34% | -63.02% | |
51 Neutral | $4.56B | 30.61 | 9.60% | 1.94% | 8.34% | -63.02% |